Incidence of Her 2 testing on pathology of patients with gastric cancer
Not Applicable
- Conditions
- Health Condition 1: null- gastric cancer
- Registration Number
- CTRI/2013/03/003461
- Lead Sponsor
- Tata Memorial centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
100 consecutive patients with gastric cancer who have a pathology specimen at our site
Exclusion Criteria
If histopathology blocks were not available
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of Her2 positivity in 100 consecutive Gastric cancer patientsTimepoint: Total duration of 6 month
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: Not Applicable